Astec LifeSciences Limited (NSE:ASTEC)
636.90
-11.55 (-1.78%)
At close: Feb 13, 2026
Astec LifeSciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 5.75 | 4.72 | 4.73 | 5.55 | 3.39 |
Cash & Short-Term Investments | 96.91 | 5.75 | 4.72 | 4.73 | 5.55 | 3.39 |
Cash Growth | 368.65% | 22.04% | -0.40% | -14.63% | 63.67% | 9.96% |
Accounts Receivable | - | 1,474 | 1,690 | 1,549 | 2,736 | 1,872 |
Other Receivables | - | 3.6 | 17.57 | 3.99 | 49.78 | 14.57 |
Receivables | - | 1,506 | 1,708 | 1,553 | 2,788 | 1,887 |
Inventory | - | 1,598 | 1,958 | 2,948 | 1,869 | 1,061 |
Prepaid Expenses | - | 46.83 | 50.06 | 49.71 | 48.67 | 27.51 |
Other Current Assets | - | 254.94 | 263.67 | 432.41 | 445.57 | 325.8 |
Total Current Assets | - | 3,411 | 3,985 | 4,989 | 5,157 | 3,304 |
Property, Plant & Equipment | - | 4,967 | 5,316 | 4,292 | 3,514 | 3,232 |
Long-Term Investments | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Other Intangible Assets | - | 234.49 | 194.16 | 159.04 | 113.9 | 51.63 |
Other Long-Term Assets | - | 201.32 | 254.33 | 354.81 | 183.05 | 187.62 |
Total Assets | - | 8,814 | 9,749 | 9,794 | 8,968 | 6,776 |
Accounts Payable | - | 816.13 | 892.78 | 1,772 | 1,898 | 1,282 |
Accrued Expenses | - | 14.56 | 20.08 | 16.51 | 12.55 | 13.18 |
Short-Term Debt | - | 2,644 | 2,830 | 2,853 | 2,394 | 1,470 |
Current Portion of Long-Term Debt | - | 101.76 | 119.37 | 450.39 | 400 | 1.68 |
Other Current Liabilities | - | 81 | 109.79 | 170.46 | 201.32 | 455.83 |
Total Current Liabilities | - | 3,657 | 3,972 | 5,262 | 4,906 | 3,223 |
Long-Term Debt | - | 2,800 | 1,990 | 108.63 | - | 400 |
Pension & Post-Retirement Benefits | - | 2.9 | 20.5 | 13.49 | 10 | - |
Long-Term Deferred Tax Liabilities | - | 0.38 | 67.6 | 209.7 | 80.82 | 54.75 |
Other Long-Term Liabilities | - | 3.67 | 4.42 | 4.78 | 4.28 | 5.17 |
Total Liabilities | - | 6,464 | 6,054 | 5,599 | 5,001 | 3,683 |
Common Stock | - | 196.11 | 196.09 | 196.06 | 195.98 | 195.88 |
Additional Paid-In Capital | - | 613.92 | 610.9 | 607.36 | 603.48 | 598.31 |
Retained Earnings | - | 1,536 | 2,882 | 3,386 | 3,162 | 2,293 |
Comprehensive Income & Other | - | 1.27 | 3.89 | 3.83 | 3.07 | 4.31 |
Total Common Equity | 4,139 | 2,347 | 3,693 | 4,194 | 3,965 | 3,092 |
Minority Interest | - | 2.71 | 2.31 | 1.92 | 1.63 | 1.39 |
Shareholders' Equity | 4,142 | 2,350 | 3,695 | 4,196 | 3,967 | 3,093 |
Total Liabilities & Equity | - | 8,814 | 9,749 | 9,794 | 8,968 | 6,776 |
Total Debt | 3,670 | 5,545 | 4,939 | 3,412 | 2,794 | 1,872 |
Net Cash (Debt) | -3,573 | -5,540 | -4,934 | -3,407 | -2,788 | -1,869 |
Net Cash Per Share | -172.23 | -282.47 | -251.61 | -173.77 | -142.26 | -95.39 |
Filing Date Shares Outstanding | 22.29 | 19.61 | 19.61 | 19.61 | 19.6 | 19.59 |
Total Common Shares Outstanding | 22.29 | 19.61 | 19.61 | 19.61 | 19.6 | 19.59 |
Working Capital | - | -245.75 | 13.33 | -273.47 | 250.89 | 81.54 |
Book Value Per Share | 192.33 | 119.70 | 188.32 | 213.90 | 202.32 | 157.84 |
Tangible Book Value | 3,891 | 2,113 | 3,499 | 4,035 | 3,851 | 3,040 |
Tangible Book Value Per Share | 180.78 | 107.74 | 178.42 | 205.79 | 196.51 | 155.21 |
Buildings | - | 2,040 | 1,700 | 1,290 | 1,286 | 691.87 |
Machinery | - | 5,032 | 3,815 | 3,201 | 3,107 | 2,104 |
Construction In Progress | - | 1.25 | 1,485 | 1,124 | 137.32 | 1,117 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.